Trademark Overview
On Friday, July 17, 2026, a trademark application was filed for THEOREMA with the United States Patent and Trademark Office. The USPTO has given the THEOREMA trademark a serial number of 99946330. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, July 17, 2026. This trademark is owned by Theorema Inc.. The THEOREMA trademark is filed in the Advertising, Business and Retail Services and Computer & Software Services & Scientific Services categories with the following description:
Business consulting services in the fields of life sciences, biotechnology, pharmaceuticals, chemistry, materials science, and related scientific disciplines; business development consulting services; business advisory services relating to the acquisition, licensing, commercialization, and management of scientific, pharmaceutical, biotechnology, and technology assets; business evaluation of scientific, pharmaceutical, biotechnology, and technology assets; matching buyers and sellers of scientific, pharmaceutical, biotechnology, and technology assets; business research and analysis relating to licensing opportunities, asset sourcing, asset acquisition, and commercialization strategies; providing business information and business intelligence relating to scientific, pharmaceutical, biotechnology, and technology markets
Software as a service (SaaS) services featuring software that utilizes artificial intelligence for scientific research, literature review, data analysis, hypothesis generation, and research workflow automation; providing temporary use of online non-downloadable software for analyzing scientific and technical data, generating research insights, and supporting research and development activities; scientific research and development services; scientific consulting services in the fields of life sciences, biotechnology, pharmaceuticals, chemistry, materials science, and related scientific disciplines; conducting scientific evaluations, analyses, and assessments relating to target discovery, biomarker discovery, translational research, scientific research prioritization, scientific asset evaluation, patent clearance, intellectual property assessments, exclusivity analyses, regulatory strategy, and submission readiness; technical due diligence services relating to scientific, pharmaceutical,...
